PHARMAGEN, INC. Accretion Expense
PHARMAGEN, INC. reported Accretion Expense of $101.97 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2013-11-14
- PHARMAGEN, INC. accretion expense for the quarter ending 2013-03-31 was $2.31K, a 80.58% decline year-over-year.
- PHARMAGEN, INC. accretion expense for the quarter ending 2012-03-31 was $11.92K.
- PHARMAGEN, INC. accretion expense for the quarter ending 2011-03-31 was $0.00.
| Period end | Accretion Expense 3 month | Accretion Expense 9 month |
|---|---|---|
| 2013-09-30 | $101.97K 10-Q · filed 2013-11-14 | |
| 2013-03-31 | $2.31K 10-Q · filed 2013-05-15 | |
| 2012-03-31 | $11.92K 10-Q · filed 2012-06-11 | |
| 2011-03-31 | $0.00 10-Q · filed 2012-06-11 |